Methylene Blue Treatment of COVID-19

PHASE2CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

November 5, 2020

Primary Completion Date

August 13, 2021

Study Completion Date

August 13, 2021

Conditions
SARS-CoV2
Interventions
DRUG

Methylene Blue

Treatment Group. Methylene Blue 100 mg capsules, twice a day for 5 consecutive days, will be added to the current therapy of the patient, if any.

DRUG

Control Test

Arm B: Control Group. Placebo capsules 100 mg twice a day for 5 consecutive days, will be added to the current therapy of the patient, if any.

Trial Locations (1)

6900

Fondazione Epatocentro Ticino, Lugano

All Listed Sponsors
lead

Fondazione Epatocentro Ticino

OTHER